Citizens Reiterates Buy Rating on NRC Health with $23 Target

Citizens reiterated its buy rating on NRC Health (NasdaqGS:NRC) on June 22, 2026. Analyst Constantine Davides set a price target of $23 for the stock. Shares of NRC Health traded near $19.35 on Tuesday.

Other Institutional Activity in NRC Health

Vanguard Capital Management opened a new position in NRC Health, acquiring 662,837 shares valued at approximately $11.3 million. Meanwhile, Kayne Anderson Rudnick Investment Management trimmed its holdings by 21,473 shares, bringing its total to 2,636,355 shares worth about $44.8 million. Morgan Stanley also reduced its stake by 1,829 shares, leaving it with 1,001,880 shares valued at $17 million. BlackRock, Inc. cut its position by 29,468 shares, ending with 975,855 shares valued at $16.6 million. Dimensional Fund Advisors reduced its holdings by 4,764 shares, holding 489,740 shares valued at $8.3 million. Conversely, Geode Capital Management increased its stake by 10,336 shares, totaling 393,847 shares worth about $6.7 million.

NRC Health Stock Down 6.5%

Shares of NasdaqGS:NRC traded near $19.35 on Tuesday. NRC Health has a market cap of $439.2 million and trades with a P/E ratio of 50.0 and a forward P/E of 16.8. The stock's beta is 0.399, indicating lower volatility compared to the market. Over the past year, NRC Health's stock has ranged from a low of $11.01 to a high of $22.79. Its 50-day moving average is $18.40, while the 200-day moving average is $16.55. The company maintains a current ratio of 0.519 and a quick ratio of 0.362, with a debt-to-equity ratio of 578.229.

Recent Earnings

NRC Health reported revenue of $138.6 million, with a revenue growth rate of 3.7%. The company achieved a net margin of 6.5% and a return on equity of 41.9%. Earnings per share were $0.39. The next earnings report is expected on July 27, 2026.

Dividend

NRC Health offers an annual dividend rate of $0.60, yielding 3.24% with a payout ratio of 143.6%.

Insider Buying and Selling at NRC Health

Several insiders have been active in buying NRC Health shares. On March 12, 2026, Executive Vice President Jason Russell bought 60,000 shares. Earlier, on February 17, 2026, EVP & CFO Shane Harrison acquired 8,000 shares at an average price of $12.27. Additionally, on January 22, 2026, Parul Bhandari and Stephen Lockhart each purchased 8,819 shares.

Analysts Set New Price Targets

On June 22, 2026, Citizens reiterated its buy rating on NRC Health with a price target of $23. The consensus among analysts is a buy recommendation, with an average target price of $23 based on multiple analyst opinions.

About NRC Health

NRC Health provides analytics and insights to improve patient and employee experiences for healthcare organizations across the United States. Based in Lincoln, Nebraska, and led by CEO Trent S. Green, the company offers solutions like market experience, patient experience, and employee engagement services. Founded in 1981, NRC Health employs 357 people and operates within the healthcare sector, specifically in health information services.

Bottom Line

Citizens' reiterated buy rating and $23 price target on NRC Health highlights ongoing interest in the company's potential. As a healthcare analytics provider, NRC Health's stock performance and institutional activity are closely watched by investors. Remember, 13F filings and analyst reports are backward-looking, reflecting past actions and opinions that may not indicate future performance.